Sumitomo Dainippon Pharma Co's market cap is currently $6.06B. The company's EPS TTM is $1.412032; its P/E ratio is 5.49; Sumitomo Dainippon Pharma Co is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in JPY
Sumitomo Dainippon Pharma Co Earnings and Revenue History
